{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:35:30Z","timestamp":1788820530938,"version":"build-2803163510"},"reference-count":27,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Saudi Med"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec><jats:title>BACKGROUND:<\/jats:title><jats:p>Brucellosis, which has profound public health and economic consequences, is endemic to Saudi Arabia.<jats:italic>Brucella<\/jats:italic>is transmitted to humans by direct contact with infected animals or by consumption of unpasteurized dairy products. Manifestations of brucellosis are protean and require a combination of drugs to prevent the emergence of resistance. The WHO recommends the use of doxycycline with rifampicin or an aminoglycoside for brucellosis, but experts in Saudi Arabia prefer to avoid the use of rifampicin and aminoglycosides to lessen the possibility of emergence of drug-resistant tuberculosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>OBJECTIVES:<\/jats:title><jats:p>Compare rifampicin and doxycycline in the treatment of human brucellosis versus various combinations of doxycycline, with either trimethoprim-sulfamethoxazole (co-trimoxazole), quinolones or aminoglycosides, and describe the clinical manifestations of brucellosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>DESIGN:<\/jats:title><jats:p>Retrospective medical record review.<\/jats:p><\/jats:sec><jats:sec><jats:title>SETTING:<\/jats:title><jats:p>Single tertiary care center.<\/jats:p><\/jats:sec><jats:sec><jats:title>PATIENTS AND METHODS:<\/jats:title><jats:p>Diagnosis of brucellosis was based on positive serology by standard agglutination test (SAT), or isolation by culture of<jats:italic>Brucella<\/jats:italic>species from blood, body fluid or tissue.<\/jats:p><\/jats:sec><jats:sec><jats:title>MAIN OUTCOME MEASURES:<\/jats:title><jats:p>Cure rate with the use of doxycycline in combination with either co-trimoxazole, quinolone or aminoglyco-sides in comparison to doxycycline\/rifampicin and the clinical features of brucellosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>SAMPLE SIZE:<\/jats:title><jats:p>123.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>In 118 (96%) patients, the median IgG\/IgM antibody titers at diagnosis and at 6 and 12 months were 1:1280\/1:1280, 1:640\/1:640, and 1:320\/1:160, respectively. There were no differences in outcome between treatment regimens, as evidenced by a significant decrease in SAT titers and symptom resolution within six months. Five (4%) patients relapsed from non-adherence to treatment, but responded well to a second course of treatment. Blood cultures were positive in 50 patients (41%) patients. Fever, arthralgia and back pain were the most common symptoms. Good serological and clinical responses were achieved in 96% of patients. Relapse in 4% (n=5) was due to self-reported non-adherence.<\/jats:p><\/jats:sec><jats:sec><jats:title>LIMITATIONS:<\/jats:title><jats:p>Retrospective, relatively small sample size.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>Doxycycline with co-trimoxazole is as efficacious as doxycycline\/rifampicin in non-focal brucellosis and is preferred in countries with a high prevalence of tuberculosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONFLICT OF INTEREST:<\/jats:title><jats:p>None.<\/jats:p><\/jats:sec>","DOI":"10.5144\/0256-4947.2021.109","type":"journal-article","created":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T12:14:36Z","timestamp":1617624876000},"page":"109-114","source":"Crossref","is-referenced-by-count":18,"title":["Clinical manifestations and treatment outcomes of human brucellosis at a tertiary care center in Saudi Arabia"],"prefix":"10.5144","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8688-7946","authenticated-orcid":true,"given":"Jameela","family":"Edathodu","sequence":"first","affiliation":[{"name":"From the Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Alamri","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadijah Ahmed","family":"Alshangiti","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura S.","family":"Alfagyh","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Alnaghmush","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Albaiz","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader","family":"Alothman","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Khalil","sequence":"additional","affiliation":[{"name":"From the Department of Biostatistics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenusha","family":"Edathodu","sequence":"additional","affiliation":[{"name":"From the Research Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman A.","family":"Alrajhi","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3134","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMra050570","article-title":"Brucellosis","volume":"352","author":"Pappas G","year":"2005","unstructured":"Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. Vol. 352, New England Journal of Medicine. 2005. p. 2325\u201336.","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","article-title":"The new global map of human brucellosis","volume":"6","author":"Pappas G","year":"2006","unstructured":"Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos E V. The new global map of human brucellosis. Lancet Infect Dis. 2006;6(2):91\u20139.","journal-title":"Lancet Infect Dis."},{"issue":"4","key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.26719\/2001.7.4-5.791","article-title":"An epidemiological profile of brucellosis in Tabuk Province, Saudi Arabia","volume":"7","author":"Elbeltagy KE","year":"2001","unstructured":"Elbeltagy KE. An epidemiological profile of brucellosis in Tabuk Province, Saudi Arabia. East Mediterr Health J. 2001;7(4\u20135):791\u20138.","journal-title":"East Mediterr Health J."},{"issue":"1","key":"e_1_3_1_5_2","first-page":"11","article-title":"Brucellosis control in Saudi Arabia: prospects and challenges","volume":"13","author":"Memish ZA","year":"2001","unstructured":"Memish ZA. Brucellosis control in Saudi Arabia: prospects and challenges. J Che-mother [Internet]. 2001;13 Suppl 1:11\u20137. Available from: papers3:\/\/publication\/uuid\/F5970577-253D-483A-9DB3-BFF5E2579C19","journal-title":"J Che-mother [Internet]"},{"issue":"1","key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jegh.2015.09.001","article-title":"Trends of reported human cases of brucellosis, Kingdom of Saudi Arabia, 2004-2012","volume":"6","author":"Aloufi AD","year":"2016","unstructured":"Aloufi AD, Memish ZA, Assiri AM, McNabb SJN. Trends of reported human cases of brucellosis, Kingdom of Saudi Arabia, 2004-2012. J Epidemiol Glob Health. 2016;6(1):11\u20138.","journal-title":"J Epidemiol Glob Health."},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/0255-0857.34758","article-title":"Review of clinical and laboratory features of human brucellosis","volume":"25","author":"Mantur BG","year":"2007","unstructured":"Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol [Internet]. 2007;25:188\u2013202. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17901634","journal-title":"Indian J Med Microbiol [Internet]"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.4103\/0256-4947.81543"},{"issue":"12","key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1086\/324489","article-title":"Epididymoorchitis due to Brucella mellitensis: a retrospective study of 59 patients","volume":"33","author":"Navarro-Mart\u00ednez a","year":"2001","unstructured":"Navarro-Mart\u00ednez a, Solera J, Corredoira J, Beato JL, Mart\u00ednez-Alfaro E, Ati\u00e9nzar M, et al. Epididymoorchitis due to Brucella mellitensis: a retrospective study of 59 patients. Clin Infect Dis. 2001;33(12):2017\u201322.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jmii.2016.02.004","article-title":"Testicular infection in brucellosis: Report of 34 cases","volume":"51","author":"Bosilkovski M","year":"2018","unstructured":"Bosilkovski M, Kamiloski V, Miskova S, Balalovski D, Kotevska V, Petrovski M. Testicular infection in brucellosis: Report of 34 cases. J Microbiol Immunol Infect. 2018 Feb;51(1):82\u20137.","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"e_1_3_1_11_2","first-page":"e250","article-title":"Follow-up standard agglutination and 2-mercaptoethanol tests in 175 clinically cured cases of human brucellosis","volume":"14","author":"Roushan MRH","year":"2010","unstructured":"Roushan MRH, Amiri MJS, Laly A, Mostafazadeh A, Bijani A. Follow-up standard agglutination and 2-mercaptoethanol tests in 175 clinically cured cases of human brucellosis. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2010 Mar;14(3):e250-3.","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis."},{"issue":"5","key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cimid.2009.06.001","article-title":"The role of Brucellacapt test for follow-up patients with brucellosis","volume":"33","author":"Bosilkovski M","year":"2010","unstructured":"Bosilkovski M, Katerina S, Zaklina S, Ivan V. The role of Brucellacapt test for follow-up patients with brucellosis. Comp Immunol Microbiol Infect Dis. 2010 Sep;33(5):435\u201342.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"12","key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(07)70286-4","article-title":"Human brucellosis","volume":"7","author":"Franco MP","year":"2007","unstructured":"Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis. 2007 Dec;7(12):775\u201386.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"e_1_3_1_14_2","article-title":"Antibiotics for treating human brucellosis","volume":"10","author":"Yousefi-Nooraie R","year":"2012","unstructured":"Yousefi-Nooraie R, Mortaz-Hejri S, Mehrani M, Sadeghipour P. Antibiotics for treating human brucellosis. Cochrane database Syst Rev. 2012 Oct;10(10):CD007179.","journal-title":"Cochrane database Syst Rev"},{"issue":"2","key":"e_1_3_1_15_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032090","article-title":"Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis","volume":"7","author":"Sol\u00eds Garc\u00eda del Pozo J","year":"2012","unstructured":"Sol\u00eds Garc\u00eda del Pozo J, Solera J. Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis. PLoS One. 2012;7(2).","journal-title":"PLoS One."},{"issue":"2","key":"e_1_3_1_16_2","first-page":"636","article-title":"Treatment of brucellosis: a systematic review of studies in recent twenty years","volume":"4","author":"Alavi SM","year":"2013","unstructured":"Alavi SM, Alavi L. Treatment of brucellosis: a systematic review of studies in recent twenty years. Casp J Intern Med. 2013;4(2):636\u201341.","journal-title":"Casp J Intern Med."},{"issue":"4","key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1440-1843.2001.00344.x","article-title":"Progressive rise of Mycobacterium tuberculosis resistance to rifampicin and streptomycin in Riyadh, Saudi Arabia","volume":"6","author":"Al-Hajjaj MS","year":"2001","unstructured":"Al-Hajjaj MS, Al-Kassimi FA, Al-Mobeireek AF, Alzeer AH. Progressive rise of Mycobacterium tuberculosis resistance to rifampicin and streptomycin in Riyadh, Saudi Arabia. Respirology. 2001 Dec;6(4):317\u201322.","journal-title":"Respirology"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2334-6-72","article-title":"Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647]","volume":"6","author":"Alp E","year":"2006","unstructured":"Alp E, Koc RK, Durak AC, Yildiz O, Aygen B, Sumerkan B, et al. Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647]. BMC Infect Dis. 2006;6:72.","journal-title":"BMC Infect Dis"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","unstructured":"Rabbani-Anari M Mehrani M Mortaz-Hejri S Sadeghipour P Yousefi-Nooraie R Jafari S. Antibiotics for treating human brucellosis. Cochrane Database of Systematic Reviews. 2008.","DOI":"10.1002\/14651858.CD007179"},{"key":"e_1_3_1_20_2","unstructured":"Corbel MJ. Brucellosis in humans and animals [Internet]. WHO. 2006. p. 1\u2013102. Available from: http:\/\/www.who.int\/csr\/resources\/publications\/Brucellosis.pdf"},{"issue":"8","key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1128\/JCM.25.8.1384-1387.1987","article-title":"Analysis of 506 consecutive positive serologic tests for brucellosis in Saudi Arabia","volume":"25","author":"Kiel FW","year":"1987","unstructured":"Kiel FW, Khan MY. Analysis of 506 consecutive positive serologic tests for brucellosis in Saudi Arabia. J Clin Microbiol. 1987 Aug;25(8):1384\u20137.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"e_1_3_1_22_2","first-page":"415","article-title":"Human brucellosis in pregnancy - an overview","volume":"20","author":"Bosilkovski M","year":"2020","unstructured":"Bosilkovski M, Arapovi\u0107 J, Keramat F. Human brucellosis in pregnancy - an overview. Bosn J basic Med Sci. 2020 Nov;20(4):415\u201322.","journal-title":"Bosn J basic Med Sci"},{"key":"e_1_3_1_23_2"},{"issue":"2","key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1258\/td.2011.100386","article-title":"Brucellosis in pregnancy","volume":"41","author":"Gulsun S","year":"2011","unstructured":"Gulsun S, Aslan S, Satici O, Gul T. Brucellosis in pregnancy. Trop Doct. 2011 Apr;41(2):82\u20134.","journal-title":"Trop Doct"},{"issue":"1","key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1128\/AAC.50.1.22-33.2006","article-title":"Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies","volume":"50","author":"Falagas ME","year":"2006","unstructured":"Falagas ME, Bliziotis IA. Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies. Antimicrob Agents Chemother. 2006 Jan;50(1):22\u201333.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7646","key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/bmj.39497.500903.25","article-title":"Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials","volume":"336","author":"Skalsky K","year":"2008","unstructured":"Skalsky K, Yahav D, Bishara J, Pitlik S, Leibovici L, Paul M. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ. 2008 Mar;336(7646):701\u20134.","journal-title":"BMJ"},{"key":"e_1_3_1_27_2","first-page":"e8167","article-title":"Brucella Endocarditis of the Native Mitral Valve Treated With Antibiotics","volume":"12","author":"Raza MA","year":"2020","unstructured":"Raza MA, Ejaz K, Kazmierski D. Brucella Endocarditis of the Native Mitral Valve Treated With Antibiotics. Vol. 12, Cureus. 2020. p. e8167.","journal-title":"Cureus"},{"issue":"1","key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/jinf.1999.0586","article-title":"Brucella bacteraemia: Clinical and laboratory observations in 160 patients","volume":"40","author":"Memish Z","year":"2000","unstructured":"Memish Z, Mah MW, Mahmoud S Al, Shaalan M Al, Khan MY. Brucella bacteraemia: Clinical and laboratory observations in 160 patients. J Infect. 2000;40(1):59\u201363.","journal-title":"J Infect"}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:04:51Z","timestamp":1671793491000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.5144\/0256-4947.2021.109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.5144\/0256-4947.2021.109"],"URL":"https:\/\/doi.org\/10.5144\/0256-4947.2021.109","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"value":"0256-4947","type":"print"},{"value":"0975-4466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}